PLCG1 Gene Mutations in Cutaneous T-Cell Lymphomas Revisited.
The observation that mutations in the phospholipase C gamma 1 (PLCG1) gene (among which p.S345F was shown to be activating) are frequent (20%) in tumoral cutaneous T-cell lymphoma (CTCL) samples raised the possibility of targeting therapies against the PLCG1 signaling pathway. However, new data by Caumont et al. in this issue of JID show that PLCG1 mutations are far less prevalent than expected in CTCLs, which tempers the initial enthusiasm. This new study finds that only 3-5% of the CTCL tumor genomes (mycosis fungoides and Sézary syndrome) harbor PLCG1 mutations.
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: c.p.tensen@lumc.nl.
Cornelis P
CP
Tensen
D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000235:genetics*; D009154:Mutation; D051966:Phospholipase C gamma / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
D051966:Phospholipase C gamma